Home › Funds › Skylands Capital, LLC › GEHC
Skylands Capital, LLC position in GEHC
GE HEALTHCARE TECHNOLOGIES I · Health Care
Skylands Capital, LLC reported holding 191,065 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q3 2026 13F filing — a position valued at US$12.5M, representing 1.64% of its reported portfolio and ranking #15 among its reported holdings. Skylands Capital, LLC has disclosed GEHC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Skylands Capital, LLC's GEHC position evolved
Skylands Capital, LLC first disclosed a stake in GEHC in Q3 2023 at 91,325 shares (US$6.2M). The position peaked in Q3 2026 at 191,065 shares, worth US$12.5M. Across 13 filings, Skylands Capital, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 191,065 shares valued at US$12.5M — a reduction of -2,975 shares quarter over quarter.. Notable position changes include a 26% increase in Q2 2025 (shares rose 2% over the following quarter), a 28% increase in Q1 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 91.33K | $6.21M | New |
| Q4 2023 | 112.05K | $8.66M | Add |
| Q1 2024 | 107.08K | $9.73M | Reduce |
| Q2 2024 | 133.53K | $10.40M | Add |
| Q3 2024 | 130.97K | $12.29M | Reduce |
| Q4 2024 | 156.79K | $12.26M | Add |
| Q1 2025 | 122.17K | $9.86M | Reduce |
| Q2 2025 | 154.09K | $11.41M | Add |
| Q3 2025 | 144.39K | $10.84M | Reduce |
| Q4 2025 | 125.54K | $10.30M | Reduce |
| Q1 2026 | 161.09K | $11.47M | Add |
| Q2 2026 | 194.04K | $12.42M | Add |
| Q3 2026 | 191.06K | $12.49M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GEHC and 13F data
GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GEHC
- Dodge & Cox 37.86M sh · $2.42B · Q2 2026
- DODGE & COX 37.86M sh · $2.42B · Q2 2026
- Harris Associates (Oakmark) 15.33M sh · $981.25M · Q2 2026
- HARRIS ASSOCIATES L P 15.33M sh · $981.25M · Q2 2026
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 13.77M sh · $900.14M · Q3 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 12.25M sh · $784.15M · Q2 2026
- TRIAN FUND MANAGEMENT, L.P. 3.09M sh · $197.49M · Q2 2026
More on Skylands Capital, LLC
FAQ
How long has Skylands Capital, LLC held GEHC?
Skylands Capital, LLC has disclosed GEHC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Skylands Capital, LLC's current position in GEHC?
As of Q3 2026, Skylands Capital, LLC holds 191.06K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $12.49M, representing 1.64% of its reported portfolio and ranking #15.
Has Skylands Capital, LLC been buying or selling GEHC?
In the latest 13F filing (Q3 2026), Skylands Capital, LLC reduced its position in GEHC. The position peaked in Q3 2026 at 191.06K shares.
Which other funds hold GEHC?
Other major institutional holders of GEHC include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.